- Home
- KALA vs EPOW Comparison
KALA vs EPOW Comparison
Compare KALA & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- EPOW
- Stock Information
- Founded
- KALA 2009
- EPOW 2014
- Country
- KALA United States
- EPOW China
- Employees
- KALA N/A
- EPOW N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- EPOW Business Services
- Sector
- KALA Health Care
- EPOW Consumer Discretionary
- Exchange
- KALA Nasdaq
- EPOW Nasdaq
- Market Cap
- KALA 26.2M
- EPOW 24.5M
- IPO Year
- KALA 2017
- EPOW 2021
- Fundamental
- Price
- KALA $5.86
- EPOW $0.98
- Analyst Decision
- KALA Strong Buy
- EPOW
- Analyst Count
- KALA 3
- EPOW 0
- Target Price
- KALA $14.00
- EPOW N/A
- AVG Volume (30 Days)
- KALA 123.2K
- EPOW 17.7K
- Earning Date
- KALA 08-05-2025
- EPOW 07-22-2025
- Dividend Yield
- KALA N/A
- EPOW N/A
- EPS Growth
- KALA N/A
- EPOW N/A
- EPS
- KALA N/A
- EPOW N/A
- Revenue
- KALA N/A
- EPOW $64,997,741.00
- Revenue This Year
- KALA N/A
- EPOW N/A
- Revenue Next Year
- KALA N/A
- EPOW N/A
- P/E Ratio
- KALA N/A
- EPOW N/A
- Revenue Growth
- KALA N/A
- EPOW 44.28
- 52 Week Low
- KALA $2.92
- EPOW $0.55
- 52 Week High
- KALA $11.20
- EPOW $1.36
- Technical
- Relative Strength Index (RSI)
- KALA 60.68
- EPOW 54.02
- Support Level
- KALA $4.36
- EPOW $0.92
- Resistance Level
- KALA $7.00
- EPOW $0.96
- Average True Range (ATR)
- KALA 0.71
- EPOW 0.06
- MACD
- KALA 0.16
- EPOW 0.01
- Stochastic Oscillator
- KALA 63.97
- EPOW 62.50
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.